Small, Caroline J.

Gut hormone PYY3-36 physiologically inhibits food intake

Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature

Regulation of Appetite and ObesityNeuropeptides and Animal Physiology

Cited by 2,351

Subcutaneous Oxyntomodulin Reduces Body Weight in Overweight and Obese Subjects

Wynne, K., Park, A. J., Small, C. J., Patterson, M., Ellis, S. M., Murphy, K. G., Wren, A. M., Frost, G. S., Meeran, K., Ghatei, M. A., et al. (2005) · Diabetes

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 435

Peptide YY3–36 and Glucagon-Like Peptide-17–36 Inhibit Food Intake Additively

Neary, N. M., Small, C. J., Druce, M. R., Park, A. J., Ellis, S. M., Semjonous, N. M., Dakin, C. L., Filipsson, K., Wang, F., Kent, A. S., et al. (2005) · Endocrinology

Regulation of Appetite and ObesityNeuropeptides and Animal Physiology

Cited by 371

Repeated Intracerebroventricular Administration of Glucagon-Like Peptide-1-(7–36) Amide or Exendin-(9–39) Alters Body Weight in the Rat**This work was supported by the United Kingdom Medical Research Council.

Meeran, K., O’Shea, D., Edwards, C. M. B., Turton, M. D., Heath, M. M., Gunn, I., Abusnana, S., Rossi, M., Small, C. J., Goldstone, A. P., et al. (1999) · Endocrinology

Regulation of Appetite and ObesityDiabetes Treatment and Management

Cited by 303